A new study of acute lymphoblastic leukemia (ALL), a blood cancer that primarily affects young children, has revealed that the disease has two distinct subtypes, and provides preliminary evidence that about 13 percent of ALL cases may be successfully treated with targeted drugs that have proved highly effective in the treatment of lymphomas in adults. Usually emerging in children between 2 and 5 years of … Continue reading Precision medicine study reveals new subtype of childhood leukemia.